| 0 (0%) | 11-30 07:31 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.37 | 1-year : | 0.49 |
| Resists | First : | 0.32 | Second : | 0.41 |
| Pivot price | 0.23  |
|||
| Supports | First : | 0.16 | Second : | 0.13 |
| MAs | MA(5) : | 0.18 |
MA(20) : | 0.25 |
| MA(100) : | 0.37 |
MA(250) : | 0.41 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 19.1 |
D(3) : | 11.1 |
| RSI | RSI(14): 33.5 |
|||
| 52-week | High : | 0.93 | Low : | 0.16 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ PRPH ] has closed above bottom band by 33.6%. Bollinger Bands are 8.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.19 - 0.19 | 0.19 - 0.19 |
| Low: | 0.17 - 0.17 | 0.17 - 0.17 |
| Close: | 0.18 - 0.18 | 0.18 - 0.18 |
Sat, 29 Nov 2025
Aug Action: How PRPH stock performs in weak economy - Market Trend Report & AI Powered Buy/Sell Recommendations - moha.gov.vn
Wed, 26 Nov 2025
ProPhase Labs Inc (PRPH) Q3 2025 Earnings Call Highlights: Strategic Initiatives and Financial ... By GuruFocus - Investing.com Canada
Wed, 26 Nov 2025
ProPhase Labs Inc (PRPH) Q3 2025 Earnings Call Highlights: Strategic Initiatives and Financial ... - Yahoo Finance
Wed, 26 Nov 2025
ProPhase Labs (NASDAQ: PRPH) to Detail BE-Smart Cancer Test, $7–14B Market Opportunity - Stock Titan
Wed, 26 Nov 2025
Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on December 1 - Sahm
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 42 (M) |
| Shares Float | 38 (M) |
| Held by Insiders | 7.9 (%) |
| Held by Institutions | 7.3 (%) |
| Shares Short | 246 (K) |
| Shares Short P.Month | 1,040 (K) |
| EPS | -2.07 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.28 |
| Profit Margin | 0 % |
| Operating Margin | -312.3 % |
| Return on Assets (ttm) | -28.9 % |
| Return on Equity (ttm) | -171.9 % |
| Qtrly Rev. Growth | -17.2 % |
| Gross Profit (p.s.) | 0.03 |
| Sales Per Share | 0.13 |
| EBITDA (p.s.) | -0.62 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -11 (M) |
| Levered Free Cash Flow | 7 (M) |
| PE Ratio | -0.11 |
| PEG Ratio | 0 |
| Price to Book value | 0.74 |
| Price to Sales | 1.54 |
| Price to Cash Flow | -0.78 |
| Dividend | 0.3 |
| Forward Dividend | 0 |
| Dividend Yield | 144% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|